相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An RNA Aptamer That Binds Carcinoembryonic Antigen Inhibits Hepatic Metastasis of Colon Cancer Cells in Mice
Young Ju Lee et al.
GASTROENTEROLOGY (2012)
A focused immune response targeting the homotypic binding domain of the carcinoembryonic antigen blocks the establishment of tumor foci in vivo
Aws Abdul-Wahid et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Clinical Evaluation of TRICOM Vector Therapeutic Cancer Vaccines
Ravi A. Madan et al.
SEMINARS IN ONCOLOGY (2012)
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination
Matteo Vergati et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer
Mahsa Mohebtash et al.
CLINICAL CANCER RESEARCH (2011)
DNA vaccine expressing repeated carcinoembryonic antigen (CEA)625-667 induces strong immunity in mice
Dan Li et al.
IMMUNOLOGY LETTERS (2011)
A Novel Anti-CEACAM5 Monoclonal Antibody, CC4, Suppresses Colorectal Tumor Growth and Enhances NK Cells-Mediated Tumor Immunity
Chaogu Zheng et al.
PLOS ONE (2011)
Definition of the expression of the human carcinoembryonic antigen and non-specific cross-reacting antigen in human breast and lung carcinomas
Paul F. Robbins et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
New Therapies for Castration-Resistant Prostate Cancer.
Dan L. Longo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen
Cinzia Remondo et al.
VACCINE (2009)
Sipuleucel-T: A vaccine for metastatic, asymptomatic, androgen-independent prostate cancer
Punam H. Patel et al.
ANNALS OF PHARMACOTHERAPY (2008)
Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses
Elizabeth K. Wansley et al.
CLINICAL CANCER RESEARCH (2008)
Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma
James L. Gulley et al.
CLINICAL CANCER RESEARCH (2008)
Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells
Michael B. Bernstein et al.
VACCINE (2008)
Transforming growth factor-β and the immune response to malignant disease
Beverly A. Teicher
CLINICAL CANCER RESEARCH (2007)
The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy
Claudia Palena et al.
CLINICAL CANCER RESEARCH (2007)
Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCVNS3 and Core proteins
Aurelia A. Haller et al.
VACCINE (2007)
Indoleamine 2,3-dioxygenase in immune suppression and cancer
Alexander J. Muller et al.
CURRENT CANCER DRUG TARGETS (2007)
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer
PM Arlen et al.
CLINICAL CANCER RESEARCH (2006)
MUC1 alters oncogenic events and transcription in human breast cancer cells
Christine L. Hattrup et al.
BREAST CANCER RESEARCH (2006)
Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer
JL Gulley et al.
CLINICAL CANCER RESEARCH (2005)
Yeasts encoding tumour antigens in cancer immunotherapy
A Franzusoff et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses
C Kudo-Saito et al.
CLINICAL CANCER RESEARCH (2005)
Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas
JL Marshall et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Humoral epitope-spreading following immunization with a HER-2/neu peptide based vaccine in cancer patients
ML Disis et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2004)
The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays
CM Britten et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
L Fong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity
AC Stubbs et al.
NATURE MEDICINE (2001)
分享论文
